STAR Fellow in Hematology/Oncology @UCLAHealth | IM @PstpUcla @DOM_UCLA | PhD @ucla @dgsomucla | MD @ZJU_China
Joined February 2018
- Tweets66
- Following131
- Followers57
- Likes79
Rui Li M.D., Ph.D. retweeted
So proud of this superstar @JordynSilvs who blew them away in a standing room only room with her presentation today!
Presented our phase II study on abemaciclib and hormonal therapy in recurrent ovarian and endometrial cancer
> ER+ Endometrial Cancer: mPFS of 9 months, highest in NSMP subgroup
> LGSOC: mPFS of 17.5mts, irrespective of KRAS status, 28% of patients on therapy for more than 3 years!
Don’t forget CDK4/6 inhibitors can cause durable disease control in hormone driven gynecologic cancers
Honored to be up there in the pursuit to help #gyncancers #ASCO26
Rui Li M.D., Ph.D. retweeted
Amazing work from our ⭐️fellow @omgitsyuliaz recipient of @ConquerCancerFd Merit Award highlighting the impact of frailty on outcomes in treated breast cancer patients.
#ASCO25 #sedraklab
Rui Li M.D., Ph.D. retweeted
First time at #SABCS24 !!
HAPPENING NOW: @UCLAHealthJCCC faculty and fellows are presenting their research posters!
@NikitaBacligMD
@AlkassisSamer
@DrKEMcCann
@SABCSSanAntonio #SABCS2024
Rui Li M.D., Ph.D. retweeted
Encouraging data on potential predictor biomarker for Dato-dxd
Trop 2 IHC expression deemed to fail as highly expressed in NSCLC
This is important because patient selection for dato-dxd is key as this is an agent not without toxicity.
But Dato-dxd not yet FDA approved
Rui Li M.D., Ph.D. retweeted
What a week with @AACR MBCO 2024 class led by @rosslevinemd @christine_lovly and Jean Tang!
High yield presentations, great networking, and essential grant writing and lab sessions. And the faculty are an inspiration 🤩
@JulieSchwarz14 @ValsamoA
Rui Li M.D., Ph.D. retweeted
What a week at the @AACR Workshop: Molecular Biology in Clinical Oncology (aka physician-scientist bootcamp)!
🔬🧬🧫💻
Grateful for the lessons learned, the colleagues and friends I’ve made this week, as well as support to attend from @VUMC_MedPSTP and @VUMCHemOnc
Rui Li M.D., Ph.D. retweeted
Results from EVOKE-01: No significant OS (primary endpoint) but lower toxicity vs. docetaxel. Could non-inferiority trials be valuable for regulatory approval despite their complexity in setting such as this one? #LungCancerResearch #ClinicalTrials #MedscapeFellows
Rui Li M.D., Ph.D. retweeted
We hope that #AACRECR trainees and mentors alike, consider how the tools for being a resilient scientist can support scientific and personal growth. We look forward to discussing this, the article, and more in San Diego! #AACRAMC #AACR24
Very proud of the #AACRAMC article "Resilience as an early career #researcher", that join together the expertise of Dr. Milgram @NIH w #tools and experiencies that were useful to members of the #AMC.
Hope it helps all #ECR in #cancerresearch! #AACR
aacr.org/professionals/membe…
Rui Li M.D., Ph.D. retweeted
Another fantastic interview with Kelly E. McCann, MD, PhD, of @UCLAHealth is in the books! To learn more about her unique experiences as a woman in oncology, check out our website. @gotoPER #WomeninOnc #MBCC24 #bcsm
Rui Li M.D., Ph.D. retweeted
On #InternationalWomensDay, we celebrate our inspiring physicians:
🩺 Dr. Neveen El-Farra is a professor of clinical medicine and a hospitalist who has received numerous awards for her teaching, including one of UCLA's highest honor for teaching awards.
@dgsomucla
Rui Li M.D., Ph.D. retweeted
We had a very productive 9th Annual Early-Career Hill Day. Our 20 AACR Associate Members are wrapping up their meetings, but you can still take action in support of early-career scientists by visiting
bit.ly/48yoSoV. #AACRontheHill #FundNIH
Rui Li M.D., Ph.D. retweeted
Many thanks to @AACR leadership for the opportunity to serve as group leader this year. Thanks to all the offices that met w/ Drs. Snider @waynestate, @LCarnahanPhd, & I for our #AACRontheHill
meetings! Grateful to have your support for @NIH funding
#FundNIH @UHhospitals @CWRU_GI – at Capitol Hill, Washington
It was my great honor to participate in the AACR Early Career Hill Day to advocate for continuous funding for cancer research. Thank you for your support from the house and senate! @RepTedLieu @SenAlexPadilla @butler. Thank all the staff from AACR for making this happen! – at Capitol Hill, Washington
Rui Li M.D., Ph.D. retweeted
Excited to see our current and former #AACRAMC members participating in #AACRontheHill for #AACRECHD24 advocating for the very important @NIH and @theNCI funding for the next fiscal year #FundNIH
Spending a day on the Hill to support @NIH funding! Add your voice by sending a message to Congress at AACR.org/ AACRECHD24. It only takes a minute! #AACRontheHill | #FundNIH
Just met legislative staff from Senator Padilla’s office to advocate for continuous increase funding for cancer research in Capital Hills! They are completely on board! Thank you @SenAlexPadilla for your continuous support! #AACRontheHill, #FundNIH – at Capitol Hill, Washington
Rui Li M.D., Ph.D. retweeted
CheckMate 77T - phase 3 trial of neoadj chemo-nivolumab followed by adjuvant nivolumab is pos for event-free survival. Results may help delineate contribution of adjuvant PD-1 blockade after neoadjuvant chemo-PD1 when looked at in context of CM816. #lcsm news.bms.com/news/corporate-…
Rui Li M.D., Ph.D. retweeted
In a meta-analysis of 8 advanced cancers other than melanoma, ipilimumab + standard dose nivolumab was not associated w/ clinically meaningful improvement in overall or progression-free survival over nivolumab alone, and had substantially higher toxicity. ja.ma/3OXvtBA